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There is limited knowledge on the relationship between diffusing capacity of the lung for
carbon monoxide (DLCO) and quantitative computed tomography (CT) measures of emphysema
and airway wall thickness.
Study question: What is the relationship between DLCO and the quantitative CT measures of
emphysema and airway wall thickness in subjects with and without COPD?
Methods: We included 288 COPD subjects (70% men) and 425 non-COPD subjects (54% men). All
subjects were current or ex-smokers older than 40 years and all subjects underwent spirom-
etry, diffusing capacity tests and CT examination. Quantitative CT measures included % low
attenuation areas <950 HU (%LAA) and standardized airway wall thickness (AWT-Pi10).
Results: Multiple linear regression analyses showed significant associations between DLCO and
both %LAA and AWT-Pi10 in the COPD group. The adjusted regression coefficients (SE) for DLCO
(mmol min1 kPa1) were 1.15 (0.11) per 10% increase in %LAA and 0.08 (0.03) per 0.1 mm
increase in AWT-Pi10, and the models’ adjusted R2 was 0.65 and 0.49, respectively.t of Thoracic Medicine, Haukeland University Hospital, Jonas Lies v. 65, N-5021 Bergen, Norway.
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344 T.B. Grydeland et al.Conclusions: CT measured emphysema explains a large fraction of the variation of DLCO among
COPD subjects, and more so in men. Airway wall thickness is also significantly associated with
DLCO, but explains a much smaller fraction of the variation.
ª 2010 Elsevier Ltd. All rights reserved.Introduction
Chronic obstructive pulmonary disease (COPD) is charac-
terized by a chronic and progressive airflow limitation and
is usually assessed by spirometry and diffusing capacity
of the lung for carbon monoxide (DLCO).
1 The observed
airflow limitation in COPD patients is caused by a mixture of
small airway disease (obstructive bronhiolitis) and paren-
chymal destruction (emphysema),1 but neither spirometry
nor DLCO can adequately separate between these two
conditions.
Quantitative computed tomography (CT) is becoming
a very common method to assess COPD related changes
in lung structure, including the airway wall thickening
associated with small airway disease and the reduced
parenchymal density associated with emphysema.2,3
Several studies have examined the correlation between
spirometry and quantitative CTmeasures of emphysema and
airways,4e8 findingmoderate to strong relationships. Several
studies have also examined the relationship between DLCO
and quantitative CT measures of emphysema, but these
studies have either been too small to allow effective
adjustment for potential confounders, or restricted to only
severe COPD (GOLD IV).5,8e13 Very few and small studies
have examined the relationship between DLCO and quanti-
tative CT measures of airway dimensions,9,10 and no data is
available on the relationship between quantitative CT
measurements and DLCO in subjects without COPD.
The objectives of this study were to examine the rela-
tionships between DLCO, estimated alveolar volume (VA)
and the diffusion coefficient (DLCO/VA), and quantitative
CT measures of emphysema (%LAA) and airway wall thick-
ness (AWT-Pi10) in a large COPD patient register and
community based sample of smokers. We also aimed to
examine how these relationships vary by COPD status,
gender, age and smoking history. We hypothesized a nega-
tive relationship between DLCO and %LAA, and no rela-
tionship between DLCO and AWT-Pi10.
Methods
This is a single center study that was conducted between
January 2003 and January 2005 in Bergen, Norway. The study
was approved by the local ethics committee and review
board, and all subjects gave informed consent. All subjects
included in the study were participants in the GenKOLS
study,14,15 but the current study was restricted to a subset
of the GenKOLS population (951/1909) that received an
optional CTscan16,17 and had validDLCOmeasurements (713/
951). The subjects were recruited from a hospital patient
register and from two general population studies,18,19 and
a total of 288 COPD subjects and 425 non-COPD subjects
were included. Enrollment criteria were: 1) Self-reported
Caucasian; 2) Age above 40; 3) Current or former smokerwithat least 2.5 pack years of smoking history; and 4) No severe
a1-antitrypsin deficiency. Asthmatics were not excluded.
More details regarding inclusion and exclusion criteria can
be found in a previously published paper.17
Subjects underwent spirometry according to American
Thoracic Society standards,20 using a Vitalograph 2160
Spirometer before and after bronchodilation with 400 mg
of salbutamol. Subjects were assessed at least 6 weeks
after any respiratory infection, but were not asked to
withhold regular medication. Local reference values for
forced expiratory volume in 1 s (FEV1) and forced expiratory
vital capacity (FVC) were used.21 COPD subjects had a post-
bronchodilatory FEV1/FVC-ratio < 0.70 and an FEV1 < 80%
of predicted.1 Non-COPD subjects had a post-bronchodila-
tory FEV1/FVC-ratio > 0.70 and an FEV1 > 80% of predicted.
Diffusing capacity
Single breath diffusing capacity of carbon monoxide
(transfer factor, DLCO) was measured with a SensorMedics
Vmax22D (VIASYS Healthcare/Cardinal Health, CA, USA),
using a gas mixture of carbon monoxide (0.3%), acetylene
(0.3%), methane (0.3%), oxygen (21%) and nitrogen. The
recommended ATS guidelines for DLCO measurements
22
were followed with one exception: A total of 148 subjects
with an inspired vital capacity (IVC) of less than 90% of
the largest previously measured FVC were not excluded.
However, separate analyses of the subjects who met
and those who did not meet that criterion were performed,
as recommended by Welle et al.23 These analyses revealed
no major differences between the two groups with regard
to group characteristics or the relationships between
DLCO and the quantitative CT measures, and the 148
subjects were consequently included in this study. Esti-
mated alveolar volume (VA) was measured from the single
breath dilution of methane, and the diffusion coefficient
(DLCO/VA) was calculated by dividing DLCO by VA. Local
reference values for DLCO, DLCO/VA and VA were used.
24
Computed tomography
The CT scans were acquired using a GE LightSpeed Ultra CT
scanner (120 kVp, 200 mA), at suspended full inspiration
(apex to base) using 1 mm slice thickness at 20 mm inter-
vals.17 The CT scans were reconstructed using both a low
spatial frequency reconstruction algorithm (“Standard”)
for density measurements, and a high spatial frequency
algorithm (“Bone”) for airway measurements. CT derived
total lung volume was measured, and a proxy for inflation
level was obtained by dividing that volume by the
predicted total lung capacity.25 This proxy was used as
a separate adjustment factor in the multiple linear regres-
sion models, but was not part of the calculation of the
extent of emphysema or airwaywall thickness. The extent of
Quantitative CT and diffusing capacity 345emphysemawas assessed using the percentage of lung voxels
with X-ray attenuation values less than 950 Hounsfield
units (HU) (percentage low attenuation areas, %LAA). The
950 HU cut-off has been shown to be appropriate for this
CT acquisition technique.26 Airways cut in cross section
(short to long axis greater than 2:3) were identified on the
CT scans and measured using the Full-Width-At-Half-
Maximumalgorithm.27 In order to reduce the technical errors
associated with very small airways, we only included airways
with an internal perimeter larger than 6 mm. To avoid
potential bias from different distribution of airway sizes
between subjects, a standardized measure for airway wall
thickness (AWT-Pi10) was derived for each subject by plot-
ting the square root of the airway wall area against the
internal perimeter of each measured airway.17 The resulting
regression line was used to calculate the square root of the
wall area for a “theoretical airway” with an internal perim-
eter of 10 mm (AWT-Pi10).7 More details regarding the CT
methodology used in this study can be found elsewhere.17
Statistics
Proportions were tested using Pearson’s chi square tests28
and means using one way analysis of variance (ANOVA).
Means are reported with standard deviations (SD). We
also tested for trends. The associations of DLCO, VA and
DLCO/VA with the explanatory variables were examined
with multiple linear regression analyses. The analyses were
performed separately for COPD subjects and non-COPDTable 1 Characteristics of the study population (n Z 713).
COPD subjec
Men n Z 20
Age, years, mean (SD) 64.2 (9.7)
Current smokers, % 47.5
Pack years, median (25, 75-perc) 30.0 (19.5, 4
Post bronchodilator FEV1% of predicted, mean (SD) 59.5 (13.3)
Hemoglobin, g/dl, mean (SD) 13.9 (1.3)
HbCO % total Hb, mean (SD) 2.4 (1.7)
Disease status
Non-COPD subjects, % 0.0
COPD subjects, GOLD Stage II, % 75.3
Stage III, % 21.8
Stage IV, % 3.0
Gas transfer
DLCO, mmol min
1 kPa1, mean (SD) 6.2 (1.9)
DLCO % pred, mean (SD) 63.6 (17.1)
VA, liters, mean (SD) 5.8 (0.9)
VA % predicted, mean (SD) 81.2 (11.0)
DLCO/VA, mmol min
1 kPa1 l1, mean (SD) 1.07 (0.28)
DLCO/VA % pred, mean (SD) 79.2 (20.5)
Quantitative CT
%LAA, median (25, 75-percentile) 5.6 (2.1, 13.
AWT-Pi10, mm, mean (SD) 5.1 (0.3)
Inflation level (CT Lung volume/Predicted TLC) 0.85
Abbreviations: %LAA (percentage low attenuation areas), AWT-Pi10
(standard deviation), COPD (Chronic obstructive pulmonary disease),subjects, and adjustments were made for gender, age, pack
years, current smoking status, hemoglobin concentration,
post-bronchodilatory FEV1 in percent predicted and inflation
level (CT measured lung volume as a fraction of the pre-
dicted total lung capacity) in the standard model (Table 3).
We also added adjustments for body mass index (BMI), car-
boxyhemoglobin (HbCO) and co-morbid heart disease in
alternate models, and we tested for possible interactions
between gender and %LAA, and between gender and AWT-
Pi10. A significance level of 0.05 was applied for all tests.
All analyses were performed with STATA 10 (StataCorp LP,
College Station, Texas, USA).
Results
A total of 951 study subjects had valid quantitative CT
scans, but 238 subjects were excluded from the current
study (n Z 713) due to missing or incomplete DLCO
measurements, and the majority of the excluded subjects
(175/238) were COPD subjects. The excluded non-COPD
subjects did not differ from the original study population
with regard to age, sex, smoking history, BMI, lung function
or quantitative CT measurements. The excluded COPD
subjects were mainly characterized by worse lung function
and more emphysema.
There was a higher percentage of men among COPD
subjects than among non-COPD subjects (p < 0.001), but
both male and female COPD subjects were evenly distrib-
uted over the GOLD stages (Table 1). The COPD subjectsts, n Z 288 Non-COPD subjects, n Z 425
2 Women n Z 86 Men n Z 229 Women n Z 196
60.2 (8.1) 55.7 (9.2) 54.4 (8.7)
58.1 38.0 45.9
0.4) 22.0 (16.8, 31.2) 18.5 (10.5, 27.7) 14.0 (7.9, 23.3)
59.4 (12.5) 94.2 (8.5) 96.2 (9.4)
13.0 (1.2) 14.2 (1.1) 12.7 (1.1)
2.7 (1.7) 2.0 (1.4) 1.9 (1.5)
0.0 100.0 100.0
80.2 0.0 0.0
18.6 0.0 0.0
1.2 0.0 0.0
4.9 (1.3) 8.7 (1.7) 6.4 (1.2)
65.3 (16.1) 83.2 (13.2) 81.0 (13.0)
4.3 (0.7) 6.6 (1.0) 4.8 (0.7)
77.8 (11.8) 88.3 (9.8) 86.3 (9.6)
1.15 (0.27) 1.33 (0.20) 1.32 (0.20)
86.9 (20.5) 95.3 (14.3) 96.5 (14.2)
6) 2.9 (1.1, 6.5) 0.8 (0.4, 1.6) 0.3 (0.1, 0.8)
4.8 (0.3) 4.9 (0.3) 4.6 (0.2)
0.93 0.68 0.76
(airway wall thickness at an internal perimeter of 10 mm), SD
TLC (Total lung capacity).
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smoked more in terms of pack years (p < 0.0001), and more
COPD subjects were current smokers (pZ 0.017) (Table 1).
In both COPD subjects and non-COPD subjects the men
were older (p < 0.0001) and had smoked more (p < 0.0001),
while more women were current smokers (p Z 0.059).
The non-COPD subjects had higher absolute and percent
predicted values of DLCO, VA and DLCO/VA (p < 0.0001)
(Table 1). Men had higher absolute values of DLCO and VA in
both COPD subjects and non-COPD subjects (p < 0.0001). In
percent of predicted values, the women had higher values
for DLCO/VA, especially among COPD subjects (p Z 0.003).
The COPD subjects had more emphysema and thicker
airway walls than the non-COPD subjects (p < 0.0001), and
men had more emphysema and thicker airway walls than
women (p < 0.0001), regardless of case-control status
(Table 1).
The mean DLCO by subgroups (tertiles of %LAA and AWT-
Pi10) is shown in Table 2. We found that increasing level
of both %LAA and AWT-Pi10 were significantly associated
with decreasing and increasing level of DLCO, respectively,
in both COPD and non-COPD subjects (p < 0.01). DLCO/VA
also decreased significantly with increasing level of %LAA (p
< 0.0001) in both COPD subjects and non-COPD subjects,
while there was no association between AWT-Pi10 and DLCO/
VA (data not shown). VA increased significantly (p < 0.0001)
with increasing level of AWT-Pi10 in both COPD and non-
COPD subjects, while VA increased significantly (p < 0.0001)
with increased level of %LAA in non-COPD subjects only (data
not shown).
The multiple linear regression analyses in Table 3 show
that %LAA was consistently and negatively associated
with DLCO in COPD subjects. This was the case even after
adjustments were made for gender, hemoglobin concen-
tration, age, height, pack years, current smoking, FEV1 inTable 2 Mean (SD) DLCO by tertiles of %LAA and AWT-Pi10.
DLCO (mmol mi
COPD subjects n
All subjects 5.8 (1.9)
Groups by tertiles of %LAA
Tertile I 6.8 (1.8)
Tertile II 6.0 (1.7)
Tertile III 4.7 (1.4)
p-value (Oneway Anova) <0.0001
p-value (NP trend ) < 0.001
Groups by tertiles of AWT-Pi10
Tertile I 5.2 (1.5)
Tertile II 5.6 (2.0)
Tertile III 6.3 (1.9)
p-value (Oneway Anova) 0.0009
p-value (NP trend ) <0.001
Tertile cut-offs %LAA
COPD subjects 2.5, 8.7
Non-COPD subjects 0.3, 0.9
Significant p-values are indicated in bold.
Abbreviations: %LAA (percentage low attenuation areas), AWT-Pi10
(standard deviation), COPD (Chronic obstructive pulmonary disease).percent of predicted and inflation level. %LAA was signifi-
cantly but positively associated with VA as well (data not
shown), but significance was lost when adjustments were
made for inflation level. The observed associations of %
LAA were less consistent in the non-COPD group, and not
significant in the fully adjusted model. The relationship
between %LAA and DLCO/VA was similar to the LAA%eDLCO
relationship described above, but was not quite as closely
associated.
The same model and adjustments were also used with
AWT-Pi10 as the main explanatory variable (Table 3). We
showed a positive association between AWT-Pi10 and DLCO
in both COPD and non-COPD subjects, but significance was
lost after adjusting for inflation level in the non-COPD
group. We did not find consistently significant associations
between AWT-Pi10 and DLCO/VA or VA.
The total explained variation (adjusted R2) of the fully
adjusted models is given in Table 3. The %LAA model
explained 65% of the variation in DLCO among COPD subjects.
When we removed %LAA from the model, the explained
variation was reduced by 16%, to 49% explained variation.
Similarly, the removal of %LAA from the DLCO/VA model
reduced the explained variation among COPD subjects by
26%. The explained variation attributable to %LAA was
only negligible in the adjusted VA models among COPD
subjects, as well as in all the models among non-COPD
subjects. The explained variation attributable to AWT-Pi10
was very small (0e2%) in all models.
Additional adjustments for BMI, HbCO and co-morbid
heart disease in the models shown in Table 3, revealed no
major changes in the observed relationships in any of the
models.
Additional analyses of the relationship between DLCO
and %LAA separately in the upper, middle and lower part of
the lung did not reveal any major differences between then1 kPa1)
Z 288 Non-COPD subjects n Z 425
7.7 (1.9)
7.3 (1.5)
7.9 (2.1)
7.8 (2.0)
0.0131
0.010
7.1 (1.6)
7.5 (1.8)
8.4 (2.0)
<0.0001
<0.001
AWT-Pi10
4.8, 5.1
4.6, 4.9
(airway wall thickness at an internal perimeter of 10 mm), SD
Table 3 Multiple linear regression analyses.
Dependent variables
DLCO (mmol min
1 kPa1)
COPD subjects Non-COPD subjects
n Z 288 n Z 425
Main independent variable Coef SE Adj R2 Coef SE Adj R2
%LAA (per 10%) L1.153 0.105 0.65 0.531 0.282 0.64
AWT-Pi10 (per 0.1 mm) 0.080 0.030 0.49 0.050 0.022 0.64
Adjustments: Sex, Hemoglobin, Age, Height, Pack years, Current Smoking, FEV1% predicted, Inflation level.
Significant coefficients are indicated with bold.
Adjusted R2 is indicated for the fully adjusted model.
Abbreviations: %LAA (percentage low attenuation areas), AWT-Pi10 (airway wall thickness at an internal perimeter of 10 mm), COPD
(Chronic obstructive pulmonary disease).
Figure 1 a. The relationship between the unadjusted model
prediction of DLCO and %LAA in male and female COPD
subjects. There is a significant interaction between sex and %
LAA when predicting DLCO. b. The relationship between the
adjusted model prediction of DLCO and %LAA in male and
female COPD subjects. Adjustments were made for Sex,
Hemoglobin, Age, Height, Pack years, Current Smoking, FEV1%
predicted and Inflation level. There is a significant interaction
between sex and %LAA when predicting DLCO.
Quantitative CT and diffusing capacity 347lung regions, but the explained variation was slightly higher
in the upper half of the lung.
Interaction analysis of the COPD subjects revealed
a significant interaction between gender and %LAA, showing
that there was a stronger negative relationship between %
LAA and DLCO in men than in women, both crude (Fig. 1a)
and fully adjusted (Fig. 1b). We observed no significant
threeeway interactions between gender, age and %LAA,
but the above described gender difference tended to
decrease with increasing age.
Finally, to assess any possible selection bias due to the
exclusion of subjects with invalid DLCO measurements, we
included all subjects with at least one DLCO measurement
(n Z 829), and performed multivariate regression analyses
using the same models as shown in Table 3. The results of
these analyses are available in the Online supplement
(Table E1), and reveal no changes in the observed rela-
tionships in any of the models.
Discussion
In this study we used a large population based sample
of COPD and non-COPD subjects to examine the relation-
ships between quantitative CT measures of emphysema and
airway wall thickness and measures of diffusing capacity.
We found significant negative associations between CT
measured emphysema and both DLCO and DLCO/VA in the
COPD group, and that these relationships were even
stronger in men. We also found a significant positive asso-
ciation between CT measured airway wall thickness and
DLCO in the COPD group. The observed associations were
less convincing in the non-COPD group.
CT measured emphysema and measures of gas
diffusion
Our study confirmed our hypothesis regarding the negative
relationship between %LAA and DLCO (and DLCO/VA) in COPD
subjects, and it also confirmed the findings of previous
studies.5,8,13 The largest of these studies, by Washko et al.8,
was restricted to patients with very severe COPD (GOLD class
IV only), and they primarily performed unadjusted correla-
tion analyses. We extend this knowledge by including GOLD
348 T.B. Grydeland et al.classes IIeIV, as well as ever-smoking non-COPD subjects,
andwe adjusted for several potential confounders, including
FEV1 in percent predicted. Our finding that %LAA can predict
DLCO beyond the effect of FEV1 in percent predicted has not
previously been shown.
Among the non-COPD subjects we found the same nega-
tive relationship between %LAA and DLCO/VA, as well as
a positive relationship between %LAA and VA, but signifi-
cance was lost when we adjusted for inflation level. In
a normal lung, there is a linear relationship between DLCO
and VA,
29 and a higher lung volume often means higher CT
transparency and %LAA. Hence, the above described loss
of significance after adjustment for inflation level is consis-
tent with the known relationship between DLCO and lung
volume. In COPD subjects, the significant negative rela-
tionship between %LAA and DLCO (and DLCO/VA) persisted
after adjustment for inflation level. This finding is not
consistent with the normal relationship between DLCO and
VA in a normal lung, and could indicate structural abnor-
malities at the alveolar level. At least for restrictive lung
diseases, the relationship between DLCO and VA has been
shown to be non-linear.30
The impaired diffusing capacity by increased emphysema
may have several explanations. First, emphysema is defined
as permanent enlargement of the airspaces distal to the
terminal bronchioles, accompanied by destruction of
their walls and without fibrosis.20 Hence, the surface area
available for gas exchange is reduced with increasing
emphysema. Second, as the relationship persisted after
adjusting for VA, increased ventilation-perfusion (V/Q)
mismatch due to emphysema related pulmonary destruction
may also explain our finding.31 V/Q mismatch is partly
related to airflow limitation and increased closing volume.
However, the %LAAeDLCO relationship persisted after
adjustment for FEV1 in percent predicted. Third, several
studies32,33 have observed impaired diffusing capacity in
systemic inflammation, and COPD may be regarded
a systemic inflammatory disease.34,35 The inflammation in
COPD may impair gas diffusion partly through a thicker
membrane through which exchange occurs, and partly
through V/Q mismatch due to capillary wall destruction.31
Previous studies8,11 have shown that the relationship
between %LAA and DLCO was stronger in the upper third
of the lung. We did not find any significant differences
between the upper, middle and lower thirds of the lung
with regard to this relationship, nor did we expect to. DLCO
is measured in an upright position, whereas CT scans are
acquired in the supine position. We therefore chose to
primarily treat the lung as a single unit.CT measured airway wall thickness and measures of
gas diffusion
This is the first quantitative CT study to compare airway wall
thickness and diffusing capacity. Reduced levels of DLCO has
traditionally been linked more to the emphysematous
phenotype than to the chronic bronchitis phenotype.36 Aziz
et al.37 have previously examined the relationship between
DLCO and CT based semi-quantitative bronchial thickness,
finding a negative relationship between the two in univar-
iate correlations, but the effect disappeared in themultivariate analyses. Hence, we did not expect to find any
strong association between DLCO and the AWT-Pi10.
Interestingly, our results contradict this hypothesis. We
found a significant positive relationship between AWT-Pi10
and DLCO in COPD subjects, although the fraction of the
explained variation of DLCO attributable to AWT-Pi10 was
very modest. We found the same significant positive rela-
tionship among non-COPD subjects, but only after adjust-
ment for inflation level. Previous studies38,39 have shown
that there is a positive relationship between DLCO and FEV1
in percent predicted, and most of the effects of airway
function on DLCO are probably adjusted for by FEV1% pre-
dicted. But while FEV1 reflects both the emphysematous and
the chronic bronchitis phenotypes of COPD, AWT-Pi10
focuses on the airways. Increased airway wall thickness
could reflect bronchial inflammation, where increased
angiogenesis and increased pulmonary blood flow could
increase gas diffusion.40 One could also speculate that
thicker airway walls mean less compliant (stiffer) airways
with a smaller closing volume and better ventilated alveoli,
and that this effect is not fully compensated for by FEV1%
predicted. In support of this, we found no significant rela-
tionship between AWT-Pi10 and DLCO/VA, where VA has
been taken into account. Another possible explanation of
the positive relationship between AWT-Pi10 and DLCO is the
inverse relationship between AWT-Pi10 and %LAA found in
subjects with severe COPD in the NETT-study.41 Although
not significant, we found the same inverse relationship
between AWT-Pi10 and %LAA in our study. As %LAA increases,
both DLCO and AWT-Pi10 decreases, and the latter twowould
be positively related simply as a result of the changes in %
LAA. In support of this, the positive relationship between
AWT-Pi10 and DLCO lost significance when we added %LAA
as an adjustment to the model.Gender differences
The negative relationship between %LAA and DLCO was
significantly stronger in male than female COPD subjects,
even after adjusting for many potential confounders. There
are several possible explanations for this. Animal models
have shown that virgin female rats and mice have higher
volume specific gas-exchange surface area (SA) and smaller
alveoli than age-matched males, although there is no
difference in mass-specific oxygen consumption.42,43 The
differences may be evolutionarily derived to help females
meet the metabolic and O2 demands of reproduction.
Female rats treated with estrogen have smaller and more
alveoli than females not receiving estrogen.44 The concen-
tration of estrogen receptors in female rat lungs is also
higher than in lungs of male rats.45 Based on data from
animal models one may speculate that increased levels of
serum estrogen and increased concentration of pulmonary
estrogen receptors in women may cause the female lung
to maintain diffusing capacity better with increased
emphysema as compared tomen. In favour of such a theory is
the fact that the observed gender difference tended to
decrease with increasing age, not unlike the difference in
estrogen level between men and women. One could also
speculate that our findings were driven by the increased
diffusing capacity seen during the luteal phase of the
Quantitative CT and diffusing capacity 349menstrual cycle in fertile women,40 but the difference per-
sisted after excluding subjects below the age of 50 years.
Another explanation could be that men may be more
exposed than women to other risk factors for emphysema
and impaired diffusing capacity unaccounted for in our
analysis. Potential candidates are passive smoking in early
life46,47 and occupational airborne agents.48,49
Strengths and limitations of the study
This study is a large single center study, which allows for
extensive adjustment for important confounders. All CT
scans were performed with the same scanner, and all
diffusing capacity measurements were performed using the
same instrument. It is the first study ever to compare
a quantitative CT measure of airway wall thickness and
diffusing capacity.
There are some limitations to this study. First, even
though subjects with a total smoking consumption as low
as 2.5 pack years were included in the study, we did not
include never-smokers. Second, the study did not include
GOLD stage 1. However, GOLD stages 2e4 are those regarded
as clinically important.50 Furthermore,we used a fixed FEV1/
FVC-ratio of 0.7 to separate COPD and non-COPD subjects,
following the GOLD guidelines.1 However, it has been
shown that the use of this fixed ratio can lead to an over-
diagnosis of COPD in the elderly.51 This could haveweakened
our findings compared to using the lower limit of normal
defined by the 5th percentile. Third, the exclusion of
subjects with missing or incomplete DLCO data could have
introduced a selection bias. However, the differences
between the included and excluded subjects were not
large, and performing themultivariate analyses of Table 3 on
all subjects with at least one DLCO measurement did not
significantly change the observed relationships (Table E1).
Fourth, we did not exclude subjects with IVC<90% of the
largest FVC. But as recommended by Welle et al.,23 this is
acceptable as long as there are no significant differences
between the two groups. Fifth, the CT scans were not spi-
rometrically gated, but it has been shown that the repeat-
ability of quantitative CT tests is high and not likely to
improve by using spirometric gating.52 Furthermore, all
analyses were adjusted for inflation level.17 Sixth, the
airway wall thickness was estimated using larger airways,
while COPD is known as a small airways disease.53,54
However, studies have shown that the inflammatory
response seen in small airways can also be seen in large
airways,55 and that CT estimates of airway wall thickness
are correlated with histological measurements of small
airway wall dimensions.27 Seventh, we used a slice/gap CT
technique, instead of the newer volumetric approach, and
this could have weakened the relationships between
AWT-Pi10 and the measures of diffusing capacity. Further-
more, the use of the full-width-at-half-maximum technique
may over-estimate airway dimensions. There are numerous
CT techniques available to measure airways, and although
it can be argued that some techniques are better than
others, no single algorithm has yet risen to be the ultimate
answer for airway wall dimensions.56 Finally, we acknowl-
edge that quantitative CT assessment of the lungs involves
a certain amount of ionizing radiation and that it is associ-
atedwith an increased risk ofmalignancy. The less expensivespirometry and DLCO measurements do not carry that
risk. However, this risk decreases with increasing age at
exposure, and the constantly developing CT technology now
provide equal or better images using lower radiation doses.
In conclusion, we have shown that quantitative CT
measures of emphysema are highly related to both diffusing
capacity and diffusing coefficient. We have also shown that
there is a positive, but not equally strong, relation between
CT measured airway wall thickness and diffusing capacity.
Both CT measures provide valuable information about the
lungs not readily available from spirometry and diffusing
capacity alone, but the modest explained variation attrib-
utable to the airway measurements warrants further
studies employing newer and more accurate assessments
of the airways.
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